PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2010 | $676,558 | Replaced |
| 1st Quarter - Report | Jul 20, 2010 | $551,889 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Establishing a regulatory approval pathway for biogeneric drugs - HR 1427/S726 Promoting Innovation and Access to Life Saving Medicine Act and HR 1548 Pathway for Biosimilars Act Items related to the application of drug benefits to public plans and health exchange, include PBM disclosure in HR 3200, S1679 America's Health Future Act, HR 3962, HR3950 Patient Protection and Affordable Care Act. H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTIN A BASS | — |
| JONATHAN M HEAFITZ | — |
| GREG SCOTT JOHNSON | — |
| MARK D MERRITT | — |
| JERRY STEFFL | — |
Medicare/Medicaid MMM
Issues related to Medicare/Medicaid drug coverage including pharmacy payments (average manufacturer price), reimbursements, competition and plan administration, electronic prescribing, chronic care, PBM disclosure. Health reform proposals impacting prescription drug coverage including formulary requirements, generic drug co-payments, direct negotiation, Medicaid rebate changes, applying Medicaid rebates in Medicare, closure of Part D coverage gap, retiree drug subsidy, funding/revenues for Health Care Reform, HR 3200, S1679 America's Health Future Act, HR 3962, HR3950 Patient Protection and Affordable Care Act. H.R.4752 - Medicare Prescription Drug Price Negotiation Act of 2010 H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTIN A BASS | — |
| JONATHAN M HEAFITZ | — |
| GREG SCOTT JOHNSON | — |
| MARK D MERRITT | — |
| JERRY STEFFL | — |
Pharmacy PHA
HR 1204 - community Pharmacy Fairness Act; Electronic Prescribing; Mail Order and Pharmacy Chronic Care Management HR 1706, S369 relating to settlement payments between brand and generic manufacturers; Issues related to oversight of pharmacy benefits for federal emloyee health benefits program; Items related to the application of drug benefits to public plans and health exchange, including PBM disclosure in HR 3200, S1679 America's Health Future Act, Issues related to generic dispensing and study of impact of state "carve-out" laws on generic utilization, HR4199 Patients Health and Real Medication Access Cost Savings Act H.R. 4872 - Health Care and Education Reconciliation Act of 2010 H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009 H.R. 4813 - To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes. H.R. 4489 - FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R. 3950 - Patient Protection and Affordable Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTIN A BASS | — |
| JONATHAN M HEAFITZ | — |
| GREG SCOTT JOHNSON | — |
| MARK D MERRITT | — |
| JERRY STEFFL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.